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Abstract
G beta 5 (Gbeta5, Gb5) is a unique G protein b subunit that is thought to be expressed as an obligate heterodimer with R7
regulator of G protein signaling (RGS) proteins instead of with G gamma (Gc) subunits. We found that D2-dopamine
receptor (D2R) coexpression enhances the expression of Gb5, but not that of the G beta 1 (Gb1) subunit, in HEK293 cells,
and that the enhancement of expression occurs through a stabilization of Gb5 protein. We had previously demonstrated
that the vast majority of D2R either expressed endogenously in the brain or exogenously in cell lines segregates into
detergent-resistant biochemical fractions. We report that when expressed alone in HEK293 cells, Gb5 is highly soluble, but is
retargeted to the detergent-resistant fraction after D2R coexpression. Furthermore, an in-cell biotin transfer proximity assay
indicated that D2R and Gb5 segregating into the detergent-resistant fraction specifically interacted in intact living cell
membranes. Dopamine-induced D2R internalization was blocked by coexpression of Gb5, but not Gb1. However, the same
Gb5 coexpression levels had no effect on agonist-induced internalization of the mu opioid receptor (MOR), cell surface D2R
levels, dopamine-mediated recruitment of b-arrestin to D2R, the amplitude of D2R-G protein coupling, or the deactivation
kinetics of D2R-activated G protein signals. The latter data suggest that the interactions between D2R and Gb5 are not
mediated by endogenously expressed R7 RGS proteins.
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Introduction
The D2-dopamine receptor (D2R), is a G protein coupled
receptor (GPCR) that is a major target of drugs used to alleviate
symptoms of schizophrenia, Parkinson’s disease and depression
[1,2]. Many of the cellular actions of GPCRs are mediated via the
activation of intracellular heterotrimeric G proteins, which consist
of a Ga subunit and a protein dimer consisting of Gb and c
subunits. When an activated GPCR encounters a trimeric G
protein, it catalyzes the exchange of guanosine-59-triphosphate
(GTP) for guanosine diphosphate (GDP) at Ga, leading to the
dissociation Ga subunit from a G protein beta-gamma dimer
(Gbc). The activated GTP-bound Ga subunit and the free Gbc
dimer regulate the activity of diverse cellular effector molecules.
Signal termination is mediated by the intrinsic guanosine-59-
triphosphatase (GTPase) activity of the Ga, which hydrolyzes the
bound GTP to GDP, allowing it to re-associate with the Gbc
dimer [3,4].
Five different G protein Gb subunits have been identified thus
far, of which the first four share 80–90% homology. The fifth,
Gb5, is an atypical member, and shares only about 50% sequence
homology with the first four members [5]. Two alternatively
spliced isoforms of Gb5 have been described. The ‘‘short’’ isoform
(Gb5) is broadly expressed in neural, neuroendocrine and other
excitable tissues such as heart muscle [5,6], while the long isoform
(Gb5L) has only been found expressed in retinal photoreceptors.
Severe phenotypes associated with the Gb5 knockout mice,
indicate Gb5 likely has many important and diverse cellular
functions. For example, Gb5 knockout mice have impaired brain
development and exhibit multiple neurological abnormalities [7–
9]. In addition, these mice have altered metabolism and abnormal
weight regulation, presumably via actions in the central nervous
system [7].
The GTPase activity of Ga G proteins is enhanced by RGS
(regulator of G protein signaling) proteins and thus RGS proteins
accelerate the rate of GPCR signal termination. All RGS proteins
have a conserved core ‘‘RGS domain’’ which is necessary and
sufficient for their GTPase accelerating protein (GAP) function
[10]. Many RGS proteins also possess additional C- and N-
terminal domains [11,12] that mediate diverse functions.
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For example, R7 RGS family proteins contain a Gc-like (GGL)
domain that has been shown to specifically bind Gb5 subunits and
enhance GAP function [5,13–16]. In fact, it is thought that
in vivo, Gb5 does not form G protein Gbc dimers, and that
complex formation between Gb5 and the Gc-like domain-
containing R7 RGS proteins is necessary for stabilizing both
Gb5 and R7 RGS proteins [5,13–16]. The genetic ablation of
Gb5 resulted in the loss of all R7 RGS proteins [14], and
conversely, Gb5 protein was not detected in the retina of a triple
knockout mouse line lacking the R7 RGS proteins, RGS6, RGS7,
and RGS11 [17]. Furthermore, the Gb5 long isoform (Gb5l) that
forms a complex with the R7 RGS protein, RGS9-1, was absent
from the photoreceptors of RGS9 knockout mice [18].
However, it has not been proven that Gb5 exists solely as a
heterodimer with R7 RGS proteins in all tissues where Gb5 may
be expressed. Alternative proteins, not abundantly expressed in
retinal cells, could contribute to stabilizing Gb5 expression in
other regions.
Complexes of Gb5 and R7 RGS proteins can target to D2R
and other GPCRs but these interactions are thought to occur
through protein domains, such as the DEP domain, that are
present within R7 RGS proteins [19–23].
We previously showed that significant proportion of cellular
D2R segregates into a biochemical fraction that is resistant to
solubilization in non-ionic detergents [24]. Subsequently, we
utilized a novel in-cell biotin-transfer assay to demonstrate that this
detergent-resistant D2R fraction originated from plasma mem-
brane micro-compartments that existed in the living cell to restrict
the accessibility of the resident D2R to other cellular proteins [25].
Conversely, the D2R that segregated into the detergent-soluble
fraction originated from plasma membrane regions that allowed
the D2R molecules to interact in a relatively unrestricted manner
with other cellular proteins.
Here we report that the coexpression of D2R causes Gb5 to
target to the detergent-resistant cellular fractions and stabilizes
Gb5 to enhance Gb5 expression. Moreover, the D2R-Gb5
interaction likely occurs independently of R7 RGS proteins
suggesting that Gb5 may have additional cellular functions in
addition to its established role as a component of the R7-RGS/
Gb5 complex.
Results
Coexpression of D2R in HEK293 cells enhances the
detergent-resistance of Gb5 even in the absence of
exogenous coexpression of R7 RGS proteins
We had previously shown that the vast majority of D2-
dopamine receptors (D2R) expressed endogenously in the brain,
or exogenously in the plasma membrane of cell lines, segregates
into cellular fractions that are resistant to solubilization in non-
ionic detergents [24] and we showed that this detergent-resistant
D2R fraction is functional and responds to dopamine [25].
Furthermore, coexpression of D2R produces translocation of
putative D2R interacting proteins, such as the RGS9-2/Gb5
complex and G proteins, from detergent-soluble to detergent-
resistant membrane fractions when the latter proteins are
expressed in cell lines [24,25]. In fact, interactions with D2R,
which is expressed at relatively high concentrations in the striatum
compared to the cortex [1,2], could explain why we and others
have found that the endogenous striatal RGS9-2/Gb5 complex is
resistant to detergent-extraction, but the same complex when
expressed in cell lines is highly soluble [24,31].
To provide further support for the idea that targeting to D2R
can contribute to enhanced detergent resistance of D2R-interact-
ing proteins the striatum, we compared the detergent-solubility of
Gb5 endogenously expressed in mouse striatum and the cortex.
We found that the percent of striatal Gb5 that was extracted into
cold solutions (4uC) of the non-ionic detergent Triton X-100 was
almost halved (from ,40% to 20%), relative to Gb5 extracted
from the cortex [24].
One explanation for the increased detergent-resistance of
striatal Gb5 is that D2R, which we have shown is highly resistant
to detergent solubilization, is expressed at high concentrations in
the striatum compared to the cortex and Gb5 is then targeted to
the detergent-resistant striatal D2R through an interaction with
RGS9-2 or other R7 RGS proteins [24]. Therefore, in a control
experiment using HEK293 cells, we tested if D2R could enhance
the detergent-resistance of Gb5 independently of exogenously
expressed R7 RGS proteins. We found that coexpression of D2R
with Gb5 in HEK293 cells significantly increased the percent of
Gb5 that segregated into the TX100-insoluble cellular fraction
(from ,40% to 70%), even in the absence of exogenously
coexpressed R7 RGS protein constructs (Fig. 1A and B). This is a
surprising result, because while endogenous expression of R7 RGS
proteins in HEK293 cells has been suggested via RNA interfer-
ence [32], a microarray analysis of mRNA levels of GPCR related
signaling proteins expressed in these cells did not detect statistically
significant levels of mRNA for any of the R7 RGS proteins [33].
Thus, transiently expressed Gb5 protein, is likely to vastly exceed
the endogenously expressed levels of R7 RGS family members in
HEK293 cells.
Coexpression of Gb5, on the other hand, did not significantly
affect the TX100-solubility of D2R protein (the percent of D2R
that was soluble when expressed alone was 21.864.7, and after
Gb5 coexpression was 30.865.4, n= 4, p.0.05, t-test, data not
shown). Figures 1C and D illustrate, as reported earlier [24,25],
that the majority (.70%) of coexpressed D2R protein segregates
into the TX100-insoluble fraction.
Since D2R coexpression increased the TX100 insolubility of
Gb5 it was important to examine the effect of dopamine
pretreatment on the TX100 solubility of both D2R and of Gb5
coexpressed with D2R. Previously, we had reported that
dopamine treatment did not affect the detergent-solubility of
D2R [24,25]. Similarly, we found that dopamine pretreatment
(10 mM for 30 min) had no effect on the D2R-mediated
recruitment of Gb5 to the TX100-insoluble cellular fraction, i.e.
dopamine pretreatment did not alter the TX100 solubility of Gb5
when coexpressed with D2R (data not shown).
We report that the closely related D2-like dopamine receptor,
D4R, also segregates into the TX100-insoluble cellular fraction
and that Gb5 is similarly retargeted to the TX100-insoluble
cellular fraction after D4R coexpression (Fig. 1A, B, C and D).
The dopamine-receptor enhancement of the detergent insolu-
bility of Gb5 was specific as D2R coexpression did not alter the
TX100-solubility of KRAS (Fig. 1E and F), a plasma membrane
targeted protein that has been well characterized in the literature
to segregate into TX100-soluble cellular fractions [34,35].
The above phenomenon is specific to dopamine receptors as we
have previously reported that coexpression of the mu opioid
receptor (MOR) did not affect the detergent-solubility of either
component of the R7 RGS protein-Gb5 complex [24].
The other, more canonical G protein Gb subunits are
intrinsically resistant to detergent solubilization [36], and thus a
similar D2R-mediated retargeting of other Gb subunits, such as
Gb1, to the TX100-insoluble cellular fraction was not observed
(Fig. S1A and B).
G Protein Beta 5 and D2-Dopamine Receptors
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D2R coexpression specifically enhances the expression
and stability of Gb5
In addition to translocating Gb5 to the TX100-insoluble
fraction we observed that the coexpression of D2R simultaneously
and dramatically increased the cellular expression of Gb5 protein
(Fig. 1A, 2A and B).
The actions of D2R in increasing Gb5 expression levels were
specific. First, coexpression of D2R increased expression levels of
Gb5 by more than 400%, but, in contrast, coexpression of the
closely related dopamine receptor, D4R, did not enhance the
expression levels of Gb5. The Gb5 expression level with D4R
coexpressed was only 87.3624.7% (mean 6 SEM, n= 4) of Gb5
levels in cells expressing Gb5 alone. Coexpression of another
Figure 1. Targeting of Gb5 to the TX100-insoluble fraction upon coexpression of D2-like dopamine receptors, D2R and D4R. A.
Representative image of a Western blot depicting the segregation of Gb5 (upper panels) and total protein (lower panels) into TX100-soluble (S) and
insoluble (I) biochemical fractions prepared from HEK293 cells transfected with cDNAs for the indicated proteins. B. Quantification of the relative
levels of Gb5 segregating into TX100-soluble (white bars) and TX100-insoluble (black bars) biochemical fractions expressed as percentage of the total
cellular Gb5 signal from the respective cellular samples (mean 6 SEM; n = 4, *p,0.01, t-test relative to cells expressing Gb5 alone. C. Representative
image of a Western blot depicting the segregation of the respective FLAG-tagged dopamine receptor proteins, D2R and D4R, into TX100-soluble (S)
and insoluble (I) biochemical fractions prepared from HEK293 cells transfected with the indicated cDNAs. D. Quantification of the relative levels of
D2R and D4R segregating into TX100-soluble (white bars) and TX100-insoluble (black bars) biochemical fractions prepared from cell samples
indicated in C (mean 6 SEM; n = 4). E. Representative image of a Western blot depicting the segregation into TX100-soluble (S) and insoluble (I)
biochemical fractions of transiently expressed KRAS-BL (upper panels) and total protein (lower panels) in HEK293 cells and effect of transient
coexpression of D2R on such segregation. F. Quantification of the relative levels of KRAS-BL segregating into TX100-soluble (white bars) and TX100-
insoluble (black bars) biochemical fractions (mean 6 SEM; n = 4).
doi:10.1371/journal.pone.0105791.g001
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GPCR, the mu opioid receptor (MOR), also did not significantly
alter the expression levels of Gb5 (Fig. 2A and B).
Second, the expression level of the G protein Gb subunit, Gb1,
was instead, significantly decreased after D2R coexpression
(Fig. 2C and D).
To explore if D2R-mediated stabilization of Gb5 contributed to
the enhanced Gb5 expression observed after D2R expression, we
treated HEK293 cells expressing Gb5 alone, or coexpressing D2R
and Gb5, with cycloheximide, a protein translation/synthesis
inhibitor, and the decay of the cellular Gb5 protein signal after
cycloheximide treatment for 3 and 6 hr was monitored by Western
blotting. We found that coexpression of D2R significantly
decreased the decay of the Gb5 signal observed at both 3 and
6 hr (Fig. 3A and B). For example, after 6 hr of cycloheximide
treatment, the levels of Gb5 protein in cells expressing Gb5 alone
had decayed to less than 30%, but in cells coexpressing D2R
greater than 60% of the original Gb5 signal remained (Fig. 3).
Thus, D2R coexpression significantly inhibited the cellular
degradation of Gb5.
An in-cell proximity biotinylation assay indicates that the
detergent-insoluble D2R is relatively accessible to Gb5
Previously, we had shown that the detergent-insoluble pool of
D2R, which forms the vast majority of the cellular D2R,
represents receptor that is micro-compartmentalized in the plasma
membrane [25]. The microcompartmentalized D2R is accessible
to proteins such as b-arrestin, which has previously been shown to
interact with the receptor. However, the microcompartmentalized
D2R does not interact readily with other randomly selected
plasma membrane-targeted proteins.
One explanation for the redistribution of Gb5 to the TX100-
insoluble cellular fraction after D2R coexpression (Fig. 1A, B, C
and D), is that Gb5 is targeted either directly or indirectly to the
TX100-insoluble microcompartmentalized D2R. Hence, we
decided to compare the accessibility of the TX100-insoluble pool
of cellular D2R to Gb5 and a randomly selected protein such as
KRAS. We could not use traditional coimmunoprecipitation
techniques [37] for probing for either direct or indirect physical
interactions between the TX100-insoluble D2R and Gb5 because
these techniques first require solubilizing the proteins in non-ionic
Figure 2. Coexpression of D2R enhances the expression of Gb5 but not of Gb1 and coexpression of MOR does not significantly alter
expression of Gb5. A. Representative images from a Western blot depicting the relative levels of expression of Gb5 (upper panels) and total cellular
protein (lower panels) in HEK293 cells transfected with cDNA for the indicated proteins. B. Quantification of the relative cellular expression levels of
Gb5 after coexpression of MOR or D2R. The Gb5 protein signal is expressed as a percent of the signal measured in cells expressing Gb5 alone (mean
6 SEM; n= 4, *p,0.05, ANOVA followed by Tukey’s post-hoc test, compared to the levels in cells expressing just Gb5). C. Representative images from
a Western blot depicting the relative levels of expression of Gb1 (upper panels) or total cellular proteins (lower panels) in HEK293 cells transfected
with cDNA for the indicated proteins. D. Quantification of the relative cellular expression levels of Gb1 after coexpression of D2R. The Gb1 protein
signal is expressed as a percent of the signal measured in cells expressing Gb1 alone (mean 6 SEM; n= 3, *p,0.05, t-test, compared to the levels in
cells expressing just Gb5).
doi:10.1371/journal.pone.0105791.g002
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detergents that preserve protein-protein interactions. Unfortunate-
ly, the vast majority of D2R is insoluble in these nonionic
detergents. Furthermore, other technologies for probing protein-
protein interactions such as fluorescence or bioluminescence
resonance energy transfer (FRET or BRET) [38] cannot report
if D2R and Gb5 molecules that specifically segregated into the
detergent-insoluble cellular fraction had also interacted in living
cells.
Thus, to compare the level of interaction of between the
TX100-insoluble D2R and Gb5 or KRAS in living cells, we
utilized a novel in-cell proximity biotinylation assay. This assay
involves the E. coli biotin ligase, BirA [25,39], which specifically
biotinylates a unique ‘‘acceptor peptide’’ sequence, not present in
mammalian proteins. An attenuated biotinylation acceptor pep-
tide substrate sequence (denoted here as AP) was inserted into the
3rd cytoplasmic loop of D2R (D2R-AP), while the BirA biotin
ligase enzyme (BL) was fused to either Gb5 (Gb5-BL) or a peptide
motif from KRAS (KRAS-BL) (Fig. 4A). The D2R-AP substrate
and the biotin ligase enzyme fusions were co-expressed in
HEK293 cells cultured in biotin-depleted medium. Following a
brief (2 min) treatment of the intact living cells with biotin, the cells
were lysed in cold (4uC) TX100 lysis buffer and separated into
TX100-soluble and insoluble fractions. Biotinylation of D2R-AP
provides evidence for interactions between the D2R-AP substrate
and coexpressed biotin ligase-containing fusions that had occurred
in the intact living cell, because these two proteins must come
within close proximity (,2.2 nm) in order for biotinylation to
occur.
The use of the technique to evaluate the level of interaction
between two proteins in living cells has been previously validated
in multiple studies. For example, the rapamycin-induced interac-
tion between the FK506 binding protein (commonly referred to as
FKBP) and the FKBP-rapamycin binding protein could be
detected by enhanced in-cell biotinylation of an FKBP-AP fusion
substrate by an FKBP-rapamycin binding protein-BL fusion [39].
Similarly, we found that the in-cell biotinylation of D2R-AP
fusions by a b-arrestin2-BL fusion protein was enhanced by
treatment of the cells with dopamine [25].
We had reported earlier that the insertion of the AP-tag into
D2R does not greatly affect its detergent solubility [25] and that
the vast majority (,80%) of the D2R-AP construct segregated into
the TX100-insoluble cellular fraction. We also showed previously,
that when D2R-AP fusion substrates and a wide variety of peptide
motifs and cellular proteins fused to the biotin ligase enzyme were
coexpressed in HEK293 cells, in almost every case, the majority of
the biotinylated D2R-AP substrate segregated into the TX100-
soluble fraction [25]. This occurred even though the vast majority
of the parent D2R-AP substrate protein localized into the TX100-
insoluble fraction [25]. These results indicate that the detergent-
resistant D2R, though functional and expressed in the plasma
membrane, as we previously showed [25], represents receptor that
is compartmentalized from interacting non-specifically with other
cellular proteins. On the other hand, the detergent-soluble D2R,
which represent a minority of the cellular D2R, likely originates
from a more fluid region of the cell membrane and can interact
randomly with other cellular proteins according to the fluid mosaic
model of Singer and Nicolson [40].
In accordance with the above results, we show that the majority
(,70%) of D2R-AP that was biotinylated by KRAS-BL (which
was determined by probing the blots with streptavidin) segregates
into the TX100-soluble fraction (Fig. 4B and C) even though the
majority (.70%) of the parent D2R-AP protein is found in the
TX100-insoluble fraction (Fig. 4B and C). An interpretation of the
above results is that the small minority of cellular D2R-AP that is
present in the TX100-soluble and hence fluid region of the plasma
membrane can interact randomly and be biotinylated by KRAS-
BL. The major cellular pool of D2R-AP (i.e. the TX100-insoluble
D2R-AP pool) is compartmentalized and the accessibility of
KRAS-BL to this pool is significantly inhibited compared to the
TX-soluble D2R-AP molecules.
In contrast, we found that the segregation of D2R-AP
biotinylated by Gb5-BL, more closely matched the segregation
of the parent D2R-AP protein, with ,70% of biotinylated D2R-
AP segregating into the TX100-insoluble fraction (Fig. 4B and C).
In other words Gb5-BL could equally access both the TX100-
insoluble and soluble pools of D2R-AP molecules. These results
may be interpreted to suggest that 1) Gb5, unlike other cellular
proteins, efficiently interacts in living cells with D2R molecules
that segregates into TX100-insoluble cellular fractions and 2) that
D2R segregating into the TX100-resistant cellular fraction (i.e. the
majority of the plasma membrane-expressed D2R) is not
compartmentalized from Gb5 as it was from KRAS and many
other cellular proteins (Fig. 4D).
Figure 3. Coexpression of D2R enhances the stability of Gb5. A.
Representative image of a Western blot which depicts Gb5 cellular
expression levels levels (upper panel) or total cellular protein (lower
panel), from HEK293 cells transiently expressing either Gb5 alone or
Gb5 coexpressed with D2R, at times, t = 0, 3, or 6 hr after treatment with
cycloheximide (100 mM). B. Quantification of the reduction in cellular
Gb5 levels after treatment of cells with cycloheximide. The Gb5 levels at
times 3 and 6 hr after cycloheximide treatment are expressed as a
percentage of the levels of Gb5 measured in cells that were not treated
with cycloheximide (mean 6 SEM; n = 4, *p,0.05, t-test, comparing to
the cells that did not coexpress D2R).
doi:10.1371/journal.pone.0105791.g003
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Effect of coexpression of Gb5 on cellular coupling
between D2R and Gao G proteins
We then tested if the coexpression of Gb5 could alter the
cellular functions of D2R. To test the effects of Gb5 coexpression
on D2R-mediated G protein activation we utilized a biolumines-
cence resonance energy transfer (BRET) based assay, recently
developed by Hollins and colleagues [41]. This assay measures the
release of free Gbc subunits from the activated G protein. The
Figure 4. Interactions of Gb5 with TX100 soluble (S) and insoluble (I) D2R populations as assessed by an in-cell ‘‘proximity biotin
transfer assay’’. A. Schematic of the Gb5-BL construct, a fusion of Gb5 with BirA, an E. coli derived biotin ligase (BL) enzyme that specifically
biotinylates a unique acceptor peptide (AP) sequence (top panel). N and C refer to the N- and C-terminus, respectively, of the fusion protein.
Schematic of KRAS-BL, a fusion of the BirA biotin ligase (BL) enzyme with the plasma membrane targeting peptide motif from KRAS (center panel).
Schematic of the D2R-AP fusion construct where the AP sequence that is specifically biotinylated by BirA was inserted into a region of the 3rd
cytoplasmic loop of FLAG-tagged D2R (bottom panel). B. Representative image of a Western blot depicting the segregation, into TX100-soluble (S)
and insoluble (I) HEK293 cellular fractions, of the D2R-AP construct that was biotinylated by either co-expressed Gb5-BL or KRAS-BL (upper panels) or
the distribution of the parent D2R-AP protein (lower panels). The left and center panels represent samples prepared from HEK293 cells transiently
coexpressing D2R and Gb5-BL. Samples in the left panel were from cells not treated with biotin (biotin2). Samples depicted in the center panel were
from cells transiently coexpressing D2R and KRAS-BL and samples depicted in the right panel were from cells transiently coexpressing D2R and Gb-BL.
Cells were cultured in biotin-depleted medium and biotinylation of the D2R-AP construct by either Gb5-BL or KRAS-BL was initiated in intact cells by
treatment with 10 mM biotin for 2 min (biotin +). Biotinylated D2R-AP segregating into TX100-soluble (S) and insoluble (I) fractions was detected by
probing the blots with streptavidin, parent D2R-AP was detected by probing identically loaded blots with FLAG antibody. C. Quantification of the
percent of the biotinylated D2R-AP segregating into TX100-insoluble (I) and soluble (S) fractions after biotinylation by either KRAS-BL or Gb5-BL
(mean 6 SEM; n= 4, *p,0.05, t-test, compared to the segregation after biotinylation by KRAS-BL). D. Schematic of an explanation for the data
presented in B and C. The majority of the D2R-AP construct is expressed in plasma membrane domains that are TX100-insoluble (black filled-in region
of the plasma membrane) but some D2R-AP is also expressed in a TX100-soluble form (white open region of the plasma membrane). Gb5-BL is able
to access, interact with and biotinylate both forms with equal efficacy (lower panel). The interactions of KRAS-BL, on the other hand, are largely
restricted to the TX100-soluble form of D2R-AP indicated that it is compartmentalized away from the TX100-insoluble D2R-AP (upper panel).
doi:10.1371/journal.pone.0105791.g004
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BRET pair that is utilized is the Gbc dimer tagged with Venus
(Gbc-Venus) and masGRK3ct-NanoLuc [42]. The use of this
system to monitor coupling between D2R and associated G
proteins has been described in detail in a previously published
study [30]. Briefly, the following proteins were coexpressed in
HEK293 cells: D2R, the D2R coupled G protein subunit, G
protein alpha (o) (Gao), Gbc-Venus and masGRK3ct-NanoLuc.
Activation of the coexpressed G proteins by dopamine-bound
D2R results in the release of the Venus-tagged Gbc dimers from
the activated Ga subunits and interaction with the NanoLuc-
tagged masGRK3ct reporter produces the BRET signal. Subse-
quent application of the D2R antagonist, haloperidol, results in the
reversal of activation of D2R-coupled Gao G proteins and a re-
equilibration of free Gbc-Venus from the Gbc-Venus-masGRKct-
NanoLuc complex to the GDP-bound Ga subunit resulting in the
reversal of the BRET signal. No significant dopamine-elicited
response was observed in cells not transfected with cDNA for
either D2R or Gao [30] indicating that the BRET signal results
from the activation of exogenously expressed Gao G proteins by
D2R.
Using this assay system we generated dopamine dose-response
curves for the D2R-mediated activation of the BRET response in
the presence or absence of coexpressed Gb5. Cells were
cotransfected with two concentrations of Gb5 cDNA: the lower
concentration, denoted as Gb5 (l) in Fig. 5, was the concentration
utilized in all of the other experiments described here and a higher
concentration, denoted as Gb5 (h), that produced much greater
Gb5 protein expression levels (. 300%). The transfection of the
lower level of Gb5 cDNA, Gb5 (l), produced no significant
alterations in the maximal dopamine response (Emax) or the
dopamine EC50 concentration (Fig. 5, A, B and C). The high Gb5
concentration, Gb5 (h), produced a small but significant increase
in the dopamine EC50 and a corresponding small but significant
decrease in the Emax.
We then examined the effects of Gb5 coexpression on the
deactivation kinetics of D2R-Gao G proteins signaling where the
dopamine signal obtained by perfusing cells with 10 nM dopamine
was reversed by the application of 100 mM haloperidol. At the
lower level of Gb5 expression, Gb5 (l), no significant effect was
observed on the deactivation kinetics (Fig. 5D and E). When Gb5
was expressed at the much higher level, Gb5 (h), a small but
significant acceleration of the deactivation kinetics was detected.
Coexpression of Gb5, but not Gb1, inhibits dopamine-
induced internalization of D2R, and Gb5 coexpression
does not affect agonist-induced internalization of MOR
To quantify receptor internalization we measured the amount
of receptor at the surface of HEK293 cells both before and after
agonist treatment through a modification of a previously described
enzyme-linked immunosorbent assay (ELISA)-based protocol (see
Materials and Methods) [43]. Treatment of cells transiently
expressing D2R or MOR for 45 min with the respective receptor
agonists, dopamine or DAMGO, significantly reduced cell surface
levels of the respective receptors (Fig. 6A and B). Coexpression of
Gb1 had no effect on the loss of cell surface D2R produced by
dopamine treatment. In contrast, coexpression of Gb5 completely
blocked the dopamine-induced internalization of D2R (Fig. 6C)
but had no effect on DAMGO-induced internalization of MOR
(Fig. 6B).
The Gb5-mediated inhibition of dopamine-induced D2R
internalization was not an artifact of alterations in surface receptor
levels, as coexpression of Gb5 had no significant effect on the cell
surface levels of D2R or MOR (Fig. S2A and B).
Coexpresson of Gb5 does not affect the dopamine-
dependent recruitment of arrestin to D2R
The canonical model for the agonist-induced internalization of
many GPCRs involves the recruitment, to the agonist-bound
GPCR, of b-arrestins, which then serve to physically bridge the
receptor to the cellular endocytotic machinery [44]. To determine
whether Gb5 inhibited dopamine-induced D2R internalization by
suppressing recruitment of b-arrestin we used the in-cell proximity
biotin-transfer assay to evaluate the actions of Gb5 on this process.
In this assay, D2R-AP and a fusion construct of b-arrestin2 and
the E. coli biotin ligase BirA (Arr-BL) (Fig. 7A) are transiently
expressed in HEK293 cells and dopamine treatment (10 mM for
30 min) significantly enhances the Arr-BL -mediated biotinylation
of D2R-AP [25] (Fig. 7B and C). However, coexpression of Gb5
had no effect on D2R-AP biotinylation suggesting that Gb5 did
not inhibit recruitment of b-arrestin to D2R.
The failure to observe any Gb5-mediated inhibition of b-
arrestin recruitment to D2R was not due to any limitation of the
proximity biotinylation assay. Previous studies have established
that it is protein kinase C (PKC)-mediated phosphorylation of
D2R and not GRK phosphorylation that is required for
dopamine-induced recruitment of b-arrestin to D2R [45–48].
We therefore performed a validation experiment by treating cells
with staurosporine, a potent PKC and serine and threonine kinase
inhibitor [49], and observed that staurosporine completely blocked
the dopamine-dependent, Arr-BL -mediated enhancement of
D2R-AP biotinylation. Additionally, we found that transient
coexpression of b-arrestin-2 was able to partially block (,50%)
the dopamine-dependent biotinylation of D2R-AP by Arr-BL as
would be expected, since the b-arrestin-2 should compete with
Arr-BL for binding to D2R-AP (Fig. S3A and B).
Discussion
D2R-Gb5 co-compartmentalization can occur
independently of R7 RGS proteins
Several lines of investigations have led to the supposition that
Gb5 is found expressed only as a heterodimer with R7 RGS family
proteins [5,13,14,17,18]. However, none of these experiments
have excluded the possibility that alternative proteins could
contribute to stabilizing Gb5 expression in some tissues. The data
presented here, using HEK293 cells, suggest the novel hypothesis
that D2R can interact with and stabilize the Gb5 protein,
independently of R7 RGS proteins.
It has been shown that the complexes of Gb5 and R7 RGS
proteins can target to D2R and other GPCRs, and these
interactions are mediated through the domains present in R7
RGS proteins such as the DEP domain [19–22]. However, the
D2R-Gb5 interactions reported here likely occur independently of
R7 RGS protein for the reasons discussed below.
First, Atwood and colleagues have conducted a microarray
screen for G protein coupled receptors (GPCR) and related
signaling molecules that are endogenously expressed in HEK293
cells and found that the detected levels of transcripts for R7 RGS
family members were below levels deemed to be statistically
significant [33]. Thus, stoichiometrically, the levels of Gb5
transiently expressed in HEK293 cells likely far exceed the levels
of any endogenously expressed R7 RGS proteins.
Furthermore, we have shown that endogenous expression of
Gb5 is not detected in HEK293 cells [24], and multiple groups,
including ours, have shown that, in heterologous expression
systems, the observed GTPase accelerating protein (GAP) function
of R7 RGS proteins is dramatically enhanced (over 3 fold) by
transient coexpression of Gb5 [15,30,50,51]. The Gb5 enhance-
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ment of GAP function likely occurs through multiple mechanisms
including 1) direct conformational alteration of R7 RGS proteins
that promote GAP function, 2) through an increase in expression
of R7 RGS proteins and 3) by facilitating the interaction of R7
RGS proteins with membrane anchors [50,52]. Thus, if a
significant proportion of the exogenously expressed Gb5 associates
with endogenously expressed R7 RGS proteins it is expected that
the formation of such a complex should substantially accelerate the
deactivation kinetics of D2R-G protein coupling. However, only a
slight acceleration was observed and only when Gb5 was
expressed at a higher level than in the other experiments used to
assess interaction with D2R (Fig. 5D and E).
We have previously reported that when R7 RGS proteins, such
as RGS9-2, and Gb5 are transiently expressed in HEK293 cells,
D2R co-expression does not significantly alter protein expression
levels of either the R7 RGS protein or Gb5 [24]. In other words,
when Gb5 is present in a complex with R7 RGS proteins, D2R
coexpression does not enhance or stabilize Gb5 protein expres-
sion. However, here we have reported that D2R coexpression can
dramatically enhance levels of transiently coexpressed Gb5 protein
Figure 5. Effect of Gb5 on dopamine-mediated activation of D2R-coupled G protein signaling as measured by a fast kinetic BRET
assay. A. Average BRET dose-repsonse curve elicited by the application of 10 pM - 10 mM concentrations of dopamine to cells expressing only D2R
(black trace) and cells transiently coexpressing low (dark grey) and high (light grey) levels of Gb5. D2R stimulation by dopamine application leads to
the dissociation of the G protein heterotrimer into Gbc-Venus and GTP-bound Gao subunits. Free Gbc-Venus interacts with masGRK3ct-NanoLuc to
produce a BRET signal. The black trace is from HEK293 cells that did not coexpress Gb5 and the dark and light grey traces are from HEK293 cells
transiently coexpressing two different levels (l, for low and h, for high) of Gb5 (mean 6 SEM; n= 4). B. Quantification of the maximal amplitude (Emax)
of the BRET signal elicited by the application of dopamine in the cells described above. The Emax only significantly differed between D2R and D2R +
Gb5 (h) (*p,0.01, ANOVA followed by Tukey’s post-hoc test). C. Quantification of the average EC50 derived for the dopamine mediated activation of
D2R in the cells described in D. The response at each dose is expressed as a percent of the average maximal response (n = 4). The EC50 (in nM) for D2R
(black bar), D2R + Gb5 (l, dark grey bar), and D2R + Gb5 (h, light grey bar) was 19.860.825, 21.360.863, and 25.460.431 (mean 6 SEM), respectively.
The EC50 only significantly differed between D2R and D2R + Gb5 (h) (*p,0.01, ANOVA followed by Tukey’s post-hoc test).D. Averaged traces (6 SEM)
of changes in the BRET signal (DBRET or the BRET response) over time obtained from HEK293 cells transfected with cDNA for D2R, Gao, Venus-Gbc,
masGRK3ct-NanoLuc and treated sequentially with dopamine (10 nM) and haloperidol (100 mM). E. Quantification of the deactivation kinetics of the
dopamine-elicited BRET response after application of the D2R antagonist, haloperidol (100 mM).
doi:10.1371/journal.pone.0105791.g005
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(Fig. 1A, 2A and B, and 3A), indicating that Gb5 is not in a
complex with endogenously expressed R7 RGS proteins.
Thus, our data suggest that, in HEK293 cells, D2R co-
compartmentalizes with Gb5 in a detergent insoluble biochemical
fraction, and in a manner that is independent of R7 RGS proteins.
From our data, it is not clear if D2R is interacting with the Gb5
monomer or with a complex of Gb5 with other cellular proteins
such a G protein Gc subunits.
D2R-Gb5 co-compartmentalization has direct cellular
consequences
We found that the co-compartmentalization 1) stabilized and
enhanced Gb5 expression and 2) inhibited dopamine-induced
D2R internalization.
It is interesting to note that while the coexpression of both D2R
and the closely related dopamine receptor, D4R, enhanced the
TX100 insolubility of Gb5, it was only D2R coexpression that
enhanced the protein expression levels of Gb5 (Fig. 1). Thus, D2R
and D4R interact differently with Gb5 and the evaluation of
effects of coexpression of D2R-D4R chimeric constructs on Gb5
expression may help to define the critical D2R epitopes that help
to stabilize Gb5 in a future study.
Gb5 at expression levels which strongly inhibited dopamine-
induced D2R internalization had no significant effect on D2R-G
protein coupling (Fig. 5A, B and C and 6A). It may be then
inferred that Gb5 does not strongly modulate D2R epitopes that
are important for activating coupled Ga G proteins but can
interfere with D2R interactions that are necessary for internalizing
the receptor.
This biased action of Gb5 in altering D2R cellular functions is
particularly interesting. It is now apparent that endogenous
agonists may stabilize multiple receptor conformations and the
agonist-bound receptor conformation that promotes G protein
activation may be different from the conformation that allow for
agonist-induced internalization of the receptor [53,54]. In fact,
biased synthetic D2R agonists have been developed that activate
non-canonical G protein-independent cellular signals but do not
promote D2R-elicited G protein signals [55]. However, we believe
that this is the first report of a GPCR-interacting cellular protein
that modulates the receptor to abolish agonist-induced internal-
ization but does not affect D2R-G protein coupling. The abolition
of dopamine-induced D2R internalization by Gb5 was not
through suppression of D2R interactions with b-arrestin, as Gb5
did not alter dopamine-induced recruitment of b-arrestin to D2R
(7B and C). Gb5 had no effect on MOR internalization indicating
that the prevention of D2R-internalization by Gb5 likely occurs
through a specific targeting of Gb5 to D2R and is not a
consequence of non-specific disruption of the cellular internaliza-
tion machinery.
A large number of studies have indicated that dopamine-
induced internalization of D2R in HEK293 cells is mediated via b-
arrestin [45,47,48]. This raises the question: how is it possible for
Gb5 to strongly block D2R internalization but have no effect on
the dopamine-mediated recruitment of b-arrestin to D2R? One
model that may be suggested as an explanation is that
internalization of D2R requires one or more bridges between
D2R and the cellular internalization machinery, that are in
addition to that made through b-arrestin. Gb5 expression disrupts
one or more of these additional connections.
The expression of D2R in detergent-insoluble plasma mem-
brane microcompartments [25] and the targeting of Gb5 to these
microcompartments did not require dopamine pretreatment,
indicating that Gb5 is preassembled in a manner that allows
Gb5 to specifically edit a subset of the actions of dopamine at
D2R.
D2R-Gb5 co-comparmentalization is not caused by non-
specific aggregation of the two proteins
Coexpression of Gb5 did not alter either the cell surface levels of
D2R, the fraction of D2R expressed at the cell surface or the
amplitude of D2R-G protein coupling, but clearly inhibited
dopamine-induced D2R internalization. These observations indi-
cate that the co-compartmentalization with D2R and stabilization
of Gb5 were not caused by non-specific aggregation of the two
proteins.
Figure 6. Effects of Gb5 and Gb1 coexpression on agonist-induced receptor internalization. A. Quantification of the relative levels of
transiently expressed cell surface D2R in HEK293 cells expressing D2R alone, D2R and Gb1 or D2R and Gb5, after treatment of with dopamine (50 mM
for 45 min). The bars represent the percentage decrease in cell surface D2R in each transfection condition compared to corresponding cells that were
not treated with dopamine (mean 6 SEM; n = 8, *p,0.01, t-test, compared to cell surface D2R signal from corresponding cells not treated with
dopamine). B. Quantification of the relative levels of transiently expressed cell surface MOR in HEK293 cells expressing MOR alone and MOR with Gb5,
after treatment of DAMGO (50 mM for 45 min). The bars represent the percentage decrease in cell surface MOR in each transfection condition
compared to corresponding cells that were not treated with DAMGO (mean 6 SEM; n= 11–12, *p,0.001, t-test, compared to cell surface MOR signal
from corresponding cells not treated with DAMGO).
doi:10.1371/journal.pone.0105791.g006
G Protein Beta 5 and D2-Dopamine Receptors
PLOS ONE | www.plosone.org 9 August 2014 | Volume 9 | Issue 8 | e105791
The majority of the D4-dopamine receptor, which is a member
of the D2-like dopamine receptor family, also segregates into
detergent-resistant cellular fractions and recruits Gb5 to the same
biochemical fraction. However, these interactions are unique and
do not extend to other cell-expressed GPCRs such as mu opioid
receptors (MOR), the vast majority of which are readily solubilized
in non-ionic detergents [24]. In addition, D2R coexpression does
not significantly alter the detergent-solubility of Gb1 (Fig. S1) or
enhance cellular Gb1 expression levels (Fig. 2C and D).
Here we have provided evidence for a novel and specific feature
of Gb5 that is significant because it suggests that Gb5 can
specifically modulate an important GPCR, D2R, to prevent
dopamine-induced D2R internalization without inhibiting G
proteins activation. Moreover this action of Gb5 appears to occur
independently R7 RGS proteins.
It is thought that Gb5 exist in cells as an obligate heterodimer
with R7 RGS proteins [5,13], but such a postulate has not been
proven. Our data suggests that in some cells, Gb5 may be
stabilized by protein partners other than R7 RGS proteins, such as
D2R. While the expression of both R7 RGS proteins and Gb5 is
thought to be broadly localized to neural, neuroendocrine and
other excitable tissues such as heart muscle [5,6,13], it is not
proven that R7 RGS proteins are coexpressed in all native cells
that express Gb5. Therefore, in some neurons, D2R and Gb5 may
be expressed together, but in the absence of R7 RGS proteins.
Furthermore, even if R7 RGS proteins are present in all cells that
express Gb5, in some of these cells the relative R7 RGS protein
expression levels may not be high enough to ensure that all of the
expressed Gb5 is bound to the R7 RGS proteins in an obligate
manner.
Nevertheless, these experiments were performed in HEK293
cells where concentrations of both D2R and Gb5 are likely to be
higher than that found in native tissue. Hence, definitive in vivo
evidence for the above suppositions will require further investiga-
tions, such as the examination of Gb5 levels in D2R-expressing
Figure 7. Effect of Gb5 coexpression on arrestin recruitment to D2R-AP upon dopamine treatment as assessed by an in-cell
‘‘proximity biotin transfer assay’’. A. Schematic of the Arr-BL construct, a fusion of arrestin and BirA, an E. coli derived biotin ligase (BL) enzyme
that specifically biotinylates a unique acceptor peptide (AP) sequence. N and C refer to the N- and C-terminus, respectively, of the fusion protein. B.
Representative images from a Western blot depicting total cellular biotinylated D2R-AP by coexpressed Arr-BL (top panels) and coexpressed Gb5
(bottom panels). The top left panel represents samples prepared from cells that were untransfected with either D2R-AP (2) or Arr-BL (2) and treated
with 10 mM biotin for 2 min (biotin +, left) or samples that were transfected with both D2R-AP (+) and Arr-BL (+) and not treated with biotin (biotin2,
right). The top center panel represents samples prepared from cells which were transfected with both D2R-AP (+) and Arr-BL (+) and treated with
vehicle (dopamine 2, left) or 10 mM dopamine for 30 min (dopamine +, right) and treated with biotin. The top right panel represents samples
prepared from cells which were transfected with both D2R-AP (+), Arr-BL (+), and Gb5 (+) and treated with vehicle (dopamine 2, left) or 10 mM
dopamine for 30 minutes (dopamine +, right) and treated with biotin (+).D2R-AP biotinylated by Arr-BL was detected by probing the blots with
streptavidin. The middle panels represent corresponding western blots from samples in the upper panel probed for Gb5. The bottom panels
represent corresponding western blots from samples in the upper panel stained for total protein. C. Quantification of the relative levels of D2R-AP
biotinylated by Arr-BL in response to dopamine treatment (10 mM for 30 min) in cells expressing only D2R-AP and Arr-BL or cells expressing D2R-AP,
Arr-BL, and Gb5. The biotinylated D2R-AP signal is expressed as a percentage of biotinylated D2R-AP signal from cells that were not treated with
dopamine (mean 6 SEM; n = 4, *p,0.05, t-test, compared to biotinyalted D2R-AP signal from corresponding cells not treated with dopamine).
doi:10.1371/journal.pone.0105791.g007
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cells in mice where all four R7 RGS protein genes are knocked
out.
Materials and Methods
Chemicals
All chemicals and reagents were purchased from Sigma-Aldrich,
Fisher Scientific or from suppliers that have been specifically
identified below.
Cell Culture and Transfection
Human embryonic kidney cells (HEK293, American Type
Culture Collection) were grown in Dulbecco’s Modified Eagle
Medium supplemented with 10% v/v fetal bovine serum,
penicillin (100 units/ml) and streptomycin sulfate (100 mg/ml).
Mammalian expression plasmids containing the appropriate
complementary DNA (cDNA) constructs were transiently trans-
fected using lipofectamine transfection reagent (LTX, Life
Technologies) according to the manufacturer’s instructions. Total
transfected DNA was maintained between groups by co-transfect-
ing empty plasmid vector pcDNA 3.1+ (Life Technologies).
cDNA Constructs
All plasmid constructs utilized below were created using
standard techniques in molecular biology. The N-terminal
FLAG-epitope (FLAG) tagged version of the long form of the
human D2-dopamine receptor (D2R) [26], the N-terminal FLAG-
tagged D4-dopamine receptor (D4R) [27], the Gb5 short isoform
construct [15], the FLAG-tagged D2R construct with the biotin
ligase acceptor peptide insertion into the 3rd cytoplasmic loop
(D2R-AP) [25], the E. coli BirA biotin-ligase fusion construct with
the membrane targeting domain of KRAS (KRAS-BL, and the b-
arrestin-2 biotin ligase fusion construct (Arr-BL) [25] have
previously been described. The D2R-AP construct consists of the
FLAG-tagged D2R into which an attenuated acceptor peptide
sequence (GLNDIFEAQKIE) is inserted between amino acids at
position 305 and 306 in the 3rd cytoplasmic loop. KRAS-BL
consisted of the following peptide sequences in order from the N to
the C-terminus: the V5 epitope-tag (V5), the BirA E. coli biotin
ligase enzyme (BL), a GSGSG linker and a membrane targeting
peptide sequence (KKKKKKSKTKCVIM) from the protein
KRAS. Arr-BL consisted of the following peptide sequences in
order from the N to the C terminus, b-arrestin-2, a GSGSG linker,
and the BirA E. coli biotin ligase enzyme (BL). The N-terminal
FLAG-tagged human G protein Gb1subunit was obtained from
the Missouri S&T cDNA Resource Center (catalog #:
GNB010FN00). The G protein beta 5-biotin ligase fusion (Gb5-
BL) was created by attaching the BirA biotin ligase enzyme to the
N-terminus of the full-length Gb5 short isoform via a two amino
acid linker. Thus, the fusion protein in order from N to C terminus
consists of BirA, an Arg-Tyr linker, the Gb5 short isoform, and a
V5 epitope tag. The cDNA for the E. coli biotin ligase, BirA (BL),
was provided by Dr. Alice Ting (Massachusetts Institute of
Technology) and was amplified by PCR. Diagrams of these
constructs are provided in Fig. 4A and 7A.
Triton X-100 Biochemical Fractionation of Proteins
The method for the Triton X-100 (TX100) biochemical
fractionation of proteins has been adapted from our previous
publication [24]. Briefly, 48 hr post transfection cells were lysed in
TX100 lysis buffer (phosphate-buffered saline, in mM: 137 NaCl,
2.7 KCl, 10 Na2HPO4, 2 KH2PO4, pH 7.4 (PBS) containing 2%
v/v of the non-ionic detergent, Triton X-100) and a 16
concentration of SigmaFast Protease inhibitor (made according
to manufacturer’s instructions, Sigma-Aldrich) for 1 hr at 4uC.
The samples were centrifuged (10,000 g, 10 min at 4uC) to pellet
the TX100-insoluble proteins. Supernatant proteins (i.e. the
TX100-soluble fraction) were precipitated by the addition of
trichloroacetic acid (TCA, final concentration 10% v/v). Super-
natant proteins were washed 36 with ice-cold 95% v/v acetone
(4uC). Both the TX100-soluble and the insoluble proteins were re-
suspended in equal volumes of SDS sample buffer (2% w/v SDS,
0.01% w/v bromophenol blue, 8 M urea, 20 mM dithiothreitol,
50 mM Tris-HCl, pH 6.8). Samples were sonicated 256 for
approximately 0.5 s at a power setting of 10 for ,0.5 s to reduce
sample viscosity prior to loading using a sonicator (XL-2000,
qSonica). Equal volumes of the samples were then resolved by
sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-
PAGE) and the relative levels of protein expression were then
compared by Western blotting.
Protein Degredation Assay
To determine the effect of D2R on the rate of degradation of
Gb5 we used cycloheximide, a translational inhibitor, to block
protein synthesis, and then measured the amount of Gb5 present
in cells at 3 and 6 hr after the addition of cycloheximide. 2.56105
HEK293 cells were transfected with appropriate cDNA plasmids
containing Gb5 with or without D2R in a 24 well-plate. At 48 and
51 hr post-transfection selected wells were treated with 100 mM
cycloheximide (time= 6 and 3 hr cycloheximide treatment,
respectively). After incubation for 3 hr (54 hr post-transfection)
all cell samples were harvested in media from multi-well plates
using a micropipetter. Cells were spun down for 5 minutes at
3006g using a benchtop centrifuge and carefully washed 36with
cold (4uC) PBS. Washed cells were then lysed by sonication on ice
after being resuspended in equivalent volumes of SDS sample
buffer. Protein samples were then incubated for 15 min at 65 uC
resolved by SDS-PAGE.
Biotinylation of D2R-AP by Biotin Ligase Fusion Proteins
We utilized an in cell biotin transfer assay to detect whether or
not Gb5 interacted with the detergentinsoluble form of D2R. The
plasmids containing cDNAs for D2R-AP, Gb5-BL or KRAS-BL
as described in Figure 4A were transfected into HEK293 cells in
biotin-free media. 48 hr post-transfection, 10 mM biotin was
added to the media. After 2 min of incubation at 25uC, the cells
were washed 36using ice-cold (4uC) 16PBS. The cells were then
vigorously resuspended in ice-cold 2% v/v TX100 lysis buffer and
incubated for 1 hr at 4uC, with vortexing every 15 min. Soluble
and insoluble proteins were then harvested using the method as
described in the ‘‘Triton X-100 Biochemical Fractionation of
Proteins’’ section.
We also used the biotinylation assay to detect recruitment of b-
arrestin 2 to D2R after stimulation by dopamine. The plasmids for
D2R-AP and Arr-BL with or without Gb5 (Fig. 7A) were
transfected into HEK293 cells growing in biotin-free media. 48
hours post-transfection, cells were treated with 10 mM dopamine
or vehicle for 30 min. Subsequently, the media containing
dopamine was removed, the cells were washed 26 with cold
(4uC) PBS, and then were treated with 10 mM biotin in 16PBS for
2 minutes. Cells were then washed 36with ice-cold PBS and then
lysed in SDS sample buffer.
Samples were then resolved by SDS PAGE. The proteins were
then transferred to methanol-wetted polyvinylidene fluoride
(PVDF) membranes and probed with streptavidin conjugated to
horseradish peroxidase (HRP). These procedures and reagents are
described in the ‘‘Western Blotting’’ section below.
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Western Blotting
Proteins were resolved by gel electrophoresis and then
transferred to methanol-wetted PVDF membranes by Western
blotting apparatus (IBI Scientfic) using electrophoresis buffer
(25 mM Tris base, 192 mM glycine, 20% v/v methanol, pH
,8.3). For antibody-based detection, PVDF membranes (Im-
mobilon-FL, EMDMillipore) were blocked by incubation with 5%
w/v nonfat dry milk reconstituted in PBS (1 hr at 20uC). For the
detection of biotinylated proteins, membranes were blocked by
incubation in 3% w/v bovine serum albumin in PBS (1 hr at
20uC). Protein loading controls that are shown are from identically
loaded gels, which were transferred to PVDF membranes, stained
with 0.01% w/v coomassie blue in 1% v/v acetic acid (5 min at
20uC) and subsequently destained in 50% methanol 5% acetic
acid (15 min at 20uC).
V5 epitope-tagged proteins (KRAS-BL and Gb5-BL) were
detected by incubating blots with an HRP-conjugated anti-V5
antibody (Invitrogen/Life Technologies, 1:5000 in 5% w/v nonfat
milk in PBS). FLAG epitope-tagged protein bands (D2R, D4R,
and MOR) were detected by incubating blots with an HRP-
conjugated mouse monoclonal anti-FLAG M2 antibody (Sigma-
Aldrich, 1:5000 dilution in 5% w/v nonfat milk in 16PBS).
Biotinylated protein (D2R-AP) bands were detected by incubating
blots with HRP-conjugated streptavidin (1:10,000 in 16PBS
containing 3% w/v BSA). Gb5 was detected by incubating blots
with rabbit polyclonal antibody CT215 (1:5000 in PBS containing
5% w/v nonfat milk) [28,29]. After incubation with the primary
antibodies or HRP-conjugated streptavidin the blots were washed
36 in PBS containing 0.1% v/v tween-20 (PBS-T). If the primary
antibody was not directly conjugated to HRP the membrane was
then incubated with appropriate HRP-conjugated secondary
antibodies (Jackson ImmunoResearch, Inc.) and washed 46 in
PBS.
Chemiluminescent signals produced by the HRP enzyme were
obtained using Supersignal West Femto substrate and detected
using a Chemidoc XRS Molecular Imager (Bio-Rad Laborato-
ries). To directly compare the signals from the TX100-soluble and
insoluble fractions of a cell sample, the proteins from these
fractions were loaded onto the same SDS-PAGE gel and
transferred to a single immunoblot. Protein samples were serially
diluted and the signals quantified to ensure that the concentrations
used for experiments was in the linear range of the signal-protein
function.
Fast Kinetic BRET Assay
The agonist effects of dopamine on G protein signaling in cells
expressing D2R was measured using a fast kinetic bioluminescence
resonance energy transfer (BRET) assay. BRET was measured
between a Gbc binding peptide motif from the protein GRK3
fused to a newly engineered luciferase variant, NanoLuc
(masGRK3ct-NanoLuc) and Gb1c2-Venus in living cells as
previously described [30]. BRET measurements were made at
room temperature using a microplate reader (POLARstar Omega,
BMG Labtech) equipped with two emission photomultiplier tubes,
with a maximum of 50 milliseconds resolution. The BRET ratio is
calculated by dividing the light emitted by Gb1c2-Venus (535 nm)
over the light emitted by masGRK3ct-NanoLuc (475 nm). The
average baseline value recorded prior to agonist stimulation was
subtracted from BRET ratio values, and the resulting difference
(DBRET) was obtained. The time constants for signal deactivation
were derived from single exponential fits of the deactivation curve
following application of 100 mM haloperidol. Kinetic analysis and
curve fitting were performed using pCLAMP 6 software (Molec-
ular Devices). The average EC50 and Emax values were derived
from separate sigmoidal dose-response curves generated by the
standard three-parameter logisitic equation using GraphPad Prism
6.0 (GraphPad Software, Inc.).
Receptor Internalization Assay
To determine the effect of overexpression of Gb subunits (Gb1
or Gb5) on receptor internalization we used an ELISA-based assay
to determine the amount of receptor present at the plasma
membrane after the application of dopamine. Day 1, 56104
HEK293 cells were transfected with appropriate cDNA plasmids
containing D2R with or without Gb1 or Gb5 or MOR with or
without Gb5, in a 96-well plate. 48 hours post-transfection cells
were treated with a saturating concentration (50 mM) of dopamine
in the case of D2R or [D-Ala(2), N-Me-Phe(4), Gly(5)-ol]-
enkephalin (DAMGO) in the case of MOR for 45 minutes. The
media was then aspirated, and cells were gently washed 36with
cold (4uC) PBS. Cells were then fixed with 4% v/v formaldehyde
in PBS, and then washed 36 with PBS. Wells were blocked for
30 minutes with 5% nonfat milk dissolved in PBS. Surface
receptor was then probed for using HRP-conjugated mouse
monoclonal anti-FLAG M2 antibody (1:5,000 dilution in 5%
nonfat milk in PBS) for 1 hour at 37uC and then washed 36with
PBS. Supersignal West Femto chemiluminescent substrate (Pierce-
Thermo Fisher Scientific) was then applied to each well and
signals were detected and quantified using a multi-well plate
compatible luminometer (Glomax).
Data Analysis
Signals from the target protein bands were quantified using
ImageJ image processing and analysis software (National Institutes
of Health, Bethesda, MD, http://rsbweb.nih.gov/ij/). Statistical
analyses were performed using Microsoft Excel or GraphPad
Prism 4 software (GraphPad Software, Inc.). Images were collected
using exposure settings that did not saturate any of the pixels
acquired by the camera. The signals resulting from detergent-
soluble and insoluble preparations of a protein, respectively, were
expressed as a fraction of the total signal and Student’s t-test for
independent means of unequal variance was used to determine if
the amounts of signal from the target protein bands in each
experimental group were significantly different. When testing the
significance of means for more than 2 experimental groups, one-
way analysis of variance (ANOVA) was used to first determine
group statistical significance and only followed by Tukey’s post-
hoc analysis if the initial comparison was found to be significant.
Supporting Information
Figure S1 TX100 solubility of Gb1 is not affected by
coexpression of D2R. A. Representative image of Western
blots depicting the segregation of transiently expressed Gb1 into
TX100-soluble (S) and insoluble (I) biochemical fractions (upper
panels) or total cellular protein (lower panels) in HEK293 cells and
the effect of transiently coexpressed D2R on this segregation. B.
Quantification of the relative levels of Gb1 segregating into
TX100-soluble (white bars) and TX100-insoluble (black bars)
biochemical fractions (mean 6 SEM; n=4).
(TIFF)
Figure S2 Coexpression of Gb5 does not affect the
ability of D2R or MOR to translocate to the cell surface.
A. Quantification of the relative levels of cell surface D2R in
HEK293 cells transiently transfected with a fixed amount of D2R
cDNA and with cDNA for either Gb1 or Gb5. The cell surface
D2R signal is expressed as a percent of the signal measured in cells
transfected with the only the fixed amount of D2R cDNA. The
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levels of D2R specifically at the cell surface was evaluated by
probing intact, non-permeabilized cells with anti-FLAG antibody
targeting the D2R-fused extracellular N-terminal FLAG tag (mean
6 SEM; n= 8–16, *p,0.01, Tukey’s post-hoc test, compared to
cells expressing D2R alone). B.Quantification of the relative levels
of cell surface MOR in HEK293 cells transiently transfected with
a fixed amoun of MOR cDNA and with cDNA for Gb5. The cell
surface MOR is expressed as a percent of the signal measured in
cells transfected with only the fixed amount of MOR cDNA. The
levels of MOR specifically at the cell surface was evaluated by
probing intact, non-permeabilized cells with anti-FLAG antibody
targeting the MOR-fused extracellular N-terminal FLAG tag
(mean 6 SEM; n= 11–12).
(TIFF)
Figure S3 Dopamine-mediated recruitment of Arr-BL to
D2R-AP is blocked by treatment with staurosporine or
partially blocked by overexpression of b-arrestin-2, as
assessed by an in-cell ‘‘proximity biotin transfer assay.’’
A. Representative images from a Western blot depicting total
cellular biotinylated D2R-AP by coexpressed Arr-BL (top panels)
and parent D2R-AP (bottom panels). The top left panel represents
samples prepared from cells which were untransfected and treated
with 10 mM biotin for 2 min (biotin +, first column) or samples
that were transfected with both D2R-AP (+) and Arr-BL (+) and
not treated with biotin (biotin 2, second column); all following
samples were transfected with D2R-AP (+) or Arr-BL (+) and
treated with biotin (+). The third and fourth column in the leftmost
panel represents basal levels of biotinylated D2R-AP (third) and
the dopamine-dependent increase in biotinylated D2R-AP
(fourth). The top center panel represents samples prepared from
cells that were pre-treated for 10 min with 10 mM staurosporine
(staurosporine +). The left column represents the D2R-AP
biotinyaltion under staurosporine treatment and the right column
represents the effect of dopamine in this condition. The top right
panel represents samples prepared from cells which were also
transfected with b-arrestin-2 in a 3:1 ratio to Arr-BL (++arrestin),
the left column represents the biotinylation of D2R-AP by Arr-BL,
and the rightmost column represents the effect of dopamine on this
condition. Biotinylated D2R-AP was detected by probing the blots
with streptavidin. The bottom panels represent corresponding
western blots from identical samples in the upper panel probed for
the parent D2R-AP protein. B. Quantification of the relative
levels of D2R-AP biotinylated by Arr-BL in response to dopamine
treatment (10 mM for 30 min) in cells expressing only D2R-AP
and Arr-BL, cells that were pre-treated for staurosporine, or cells
transfected with 3:1 b-arrestin-2: Arr-BL. Bars represent the
dopamine-dependent percentage increase of biotinylated D2R-AP
in each treatment condition (mean 6 SEM; n= 4, *p,0.05,
ANOVA followed by Tukey’s post-hoc test, compared to the
increase in biotinylated D2R-AP in cells only treated with
dopamine).
(TIFF)
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